Литература 1. Новиков Ю.К. Медицина для всех 1998; 2(8):10–2. 2. Таточенко В.К., Федоров А.М. Детский доктор 2000; 2: 14–17. 3. Таточенко В.К., Федоров А.М. Пульмонология 1997; Приложение: 21–4. 4. Таточенко В.К., Федоров А.М., Хайрулин Б.Е. Педиатрия 1992; 4–6: 38–42. 5. Середа Е.В. Медицина для всех 1998; 2(8): 13–21. 6. Страчунский Л.С., Богомильский М.Р. Детский доктор 200; 2: 32–3. 7. Acher MI et al. Eur Resp J 1995; 8: 483–91. 8. Ahav G, Toledano Y, Engelhard D et al. Medicine (Baltimor) 1997; 76: 295–303. 9. Arnold KE, Leggiadro RJ, Breinman RF et al J Pediatr 1996; 128: 757–64. 10. Backhaus RJ, Kapasi M., Noble I. Br J Med Econ 1995; 8: 195–210. 11. Ball P, Geddes A, Rolinson G. J Chemother 1997; 9 (3): 167–8. 12. Ballow CH, Jones RN, Johanson D et al Abstracts of the 37th ISAAC, Toronto, Ontario, Canada, Sept. 28. 1, 1997, Abstract E-118. 13. Bateman K, Dean NC, Hadlock CJ et al Chest 1996; 110 (Suppl.): 30S. 14. Bergogne-Berezin E. 7th Intern Cong. Infect. Dis. HongKong. 1996, abst. 6.003. 15. Bergone-Berzin E. Drug Investig 1993; 6 (Suppl.1): 52–54. 16. CDS: Pneumonia and influenza death rates: United States 1979-1994. MMWR 1995; 44: 535–7. 17. Chan R, Henerych L, Clancy L et al Br J Med 1995; 310: 1360–2. 18. Cherian T, Steinhoff MS, Harrison LH et al JAMA. 1994; 271: 695–7. 19. Cook RC, Zachariah J, Gree F, Harrison HE. Infect 1997; 16: 463–70. 20. Data on file. Rhone-Poulenc Rorer. Результаты применения спирамицина при внебольничных пневмониях. Многоцентровое исследование в России. 21. Doern GV, Brueggeman A, Holley HPJ et al. Antimicrob Agents Chemother 1996; 40: 1208–13. 22. Enarson P, Enarson DA International Union Against Tuberculosis and Lung Disease. A Guide for Low Income Countries. 1997. 23. Fang GD, Fine M., Orloff J et al Medicine 1990; 69: 307–16. 24. Fine MJ, Smith MA, Carson CA et al JAMA. 1996; 275: 134–41. 25. Friedland IR, Klugman KP Am J Dis Child 1992; 146: 920–3. 26. Frydman AM, LeRoux Y, Desnottes JP et al J Antimicr Chemother 1988; 22 (Suppl.B): 93–103. 27. Gilbert K, Fine M Sem Resp Inf 1994; 9: 140–52. 28. Gomez-Barreto D. Drug investigation 1991; 3 (Suppl.3): 17–20. 29. Gooch WM, Congeni BI, Senson E, Snellman LW Curr.Ther.Res. 1985; 37: 178–83. 30. Gordon G, Throop D, Berberian L et al Am J Respir Crit Care Med 1995; 15 (Suppl A) 257. 31. Gruneberg RN, Felmihgham D. Diagn. Microbiol. Infect Dis 1996; 25: 169–81. 32. Gruneberg RN. J Antimicrob Chemother 1996; 38, (Suppl. A): 155–70. 33. Guest JF, Morris A Eur Resp J 1997; 10(7): 1530–4. 34. Gwaltney J, Scheld M, Sande M, Sydnor A. J. Аllergy Clin Immunol 1992; 90: 457–62. 35. Holmes SJ, Solomon SL, Morrow AL et al Pediatr Res 1997; 41, 122A 36. Jabes D, Nachman S, Tomasz A. J Inf Dis 1989; 159: 16–25. 37. Jacobs MR J Chemother 1997; 9 (Suppl.3): 10–7. 38. Jorgensen JH. Clin Inf Dis 1992; 14: 1119–23. 39. Klugman K, Moser W. The 3rd Int.Conf.on the Macrolides, Azalides and Streptogramins, Lisbon/ 1996.Abst. 301. 40. Klugman KP J Antimicrob Chemother 1996; 38 (Suppl. A): S 133–40. 41. Labro MT. Drug Invest 1993; 6 (Suppl.1):, 15–28. 42. Leroy O, Santre C, Beuscart C Intencive Care Med 1995; 21: 24–31. 43. Levy M, Dromer F, Brion N et al Chest 1988; 92: 43–8. 44. Mandell LA Infect Med 1998; 15 (Suppl.E): 34–5. 45. Marrie TJ, Durant H., Yates L. Reviews infectious Diseases 1989; 11: 568–89. 46. Martinez FD, Wright AL, Taussing LM et al New Engl J Med 1995; 332: 133–8. 47. McCaig, Hughes JM JAMA 1995; 273: 214–9. 48. Moine P, Vercken J-B, Chevret S et al Chest 1994; 105: 1487–95. 49. Mufson MA. In: Mundell GL, Douglas RG, Bennet JE ads. Principil and Practice of Infection Disease. 3rd edn New York: Churchill Livingstone, 1990; 1539–50. 50. National Center for Health Sttistics: National hospital Discharge survey:Annual summary 1990, Vital Health Stat 1992; 13: 1–225. 51. Nequist A-Ch, Conzales R, Steiner J JAMA (Россия).1998; 4 (1): 52–6. 52. Neu HC, Wilson APR, Gruenberg RN J Chemother 1993; 5: 67–93. 53. Nyfeler B, Pichler W Clin Exp Allergy 1997; 27 (2): 175–81. 54. Pachon J, Prados MD, Capote F et al Am Rev respir Dis 1990; 142: 369–73. 55. Paradise JL. Pediatr Infect Dis 1996;15: 963–5. 56. Pechere J-C. Inf Med 1998, 15 (Suppl.E):46–54. 57. Pichler W et al Meeting Swiss Society for Аllergy and Immunology, 1997. March. Zurich. Abstract. 58. Rahal JJ, Urban C, Horn D et al JAMA. Россият.2 (8): 32–9. 59. Rylander E, Pershagen G, Ericcson M Eur . Epidemio. 1993; 9б: 517–26. 60. Schaab UB, Pgenniger J, Wedgwood-Kruscko J, J Antimicr Chemothe. 1987; 19: 385–91. 61. Seggev. J.S.JAMA 1998; 124: 921–5. 62. Sibbald, Rink E. Br J Pract 1990; 40: 338–40. 63. Sutcliffe J, Grebe T, Tait-Kamradt, Wondrack L. Antimicrob Agents Chemother 1996; 40: 2562–66. 64. Thornsberry C, Ogilvie P, Kahn JB et al Diagn Microbiol Inf Dis 1997; 29: 249–57. 65. WHO. Management of the young child with acute respiratory infection. The WHO, ACT International, Atlanta, Georgia, USA, 1991. 66. WНО (1997). Statistic database. Russia (Internet) 10.01.00 http://www.who.int/whosis/statistics. 67. WHО (1997). The first global review and coodination meeting on integrated management of childhood illness (IMCI). (Internet) 12.01.00 http://www.who.int/chd/imcid/report/draft1.htm.
Уважаемый посетитель!
Чтобы распечатать файл, скачайте его (в формате Word).
Ссылка на скачивание - внизу страницы.